SkyePharma's Asthma Drug Finally Approved in Europe
By Nuala Moran
Wednesday, July 11, 2012
LONDON The asthma treatment Flutiform finally won the seal of the European Commission recently, more than 12 years after SkyePharma plc set its sights on what it thought would be the relatively straightforward development of a combination product based on two marketed drugs.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.